Smith SA - Search Results

1

BRL 35135, a potent and selective atypical beta-adrenoceptor agonist.

Cawthorne MA, Sennitt MV, Arch JR, Smith SA. Cawthorne MA, et al. Among authors: smith sa. Am J Clin Nutr. 1992 Jan;55(1 Suppl):252S-257S. doi: 10.1093/ajcn/55.1.252s. Am J Clin Nutr. 1992. PMID: 1345889 Review.

2

Effects of BRL 35135, a beta-adrenoceptor agonist with novel selectivity, on glucose tolerance and insulin sensitivity in obese subjects.

Mitchell TH, Ellis RD, Smith SA, Robb G, Cawthorne MA. Mitchell TH, et al. Among authors: smith sa. Int J Obes. 1989;13(6):757-66. Int J Obes. 1989. PMID: 2695481

3

The beta-adrenoceptor selectivity profile of BRL 37344 in the pithed rat.

Oriowo MA, Sennitt MV, Smith SA, Ruffolo RR Jr, Cawthorne MA. Oriowo MA, et al. Among authors: smith sa. J Auton Pharmacol. 1994 Oct;14(5):337-44. doi: 10.1111/j.1474-8673.1994.tb00614.x. J Auton Pharmacol. 1994. PMID: 7829538

4

Anti-hyperglycaemic action of BRL 26830, a novel beta-adrenoceptor agonist, in mice and rats.

Sennitt MV, Arch JR, Levy AL, Simson DL, Smith SA, Cawthorne MA. Sennitt MV, et al. Among authors: smith sa. Biochem Pharmacol. 1985 Apr 15;34(8):1279-85. doi: 10.1016/0006-2952(85)90506-4. Biochem Pharmacol. 1985. PMID: 2859857

5

Effects of BRL 26830, a novel beta-adrenoceptor agonist, on glucose tolerance, insulin sensitivity and glucose turnover in Zucker (fa/fa) rats.

Smith SA, Levy AL, Sennitt MV, Simson DL, Cawthorne MA. Smith SA, et al. Biochem Pharmacol. 1985 Jul 15;34(14):2425-9. doi: 10.1016/0006-2952(85)90521-0. Biochem Pharmacol. 1985. PMID: 2861816

6

Brown adipose tissue is a major site of glucose utilisation in C57Bl/6 ob/ob mice treated with a thermogenic beta-adrenoceptor agonist.

Young P, Cawthorne MA, Smith SA. Young P, et al. Among authors: smith sa. Biochem Biophys Res Commun. 1985 Jul 16;130(1):241-8. doi: 10.1016/0006-291x(85)90408-5. Biochem Biophys Res Commun. 1985. PMID: 4026829

7

Effects of novel beta-adrenoceptor agonists on carbohydrate metabolism: relevance for the treatment of non-insulin-dependent diabetes.

Cawthorne MA, Carroll MJ, Levy AL, Lister CA, Sennitt MV, Smith SA, Young P. Cawthorne MA, et al. Among authors: smith sa. Int J Obes. 1984;8 Suppl 1:93-102. Int J Obes. 1984. PMID: 6152558

8

Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling.

Young PW, Cawthorne MA, Coyle PJ, Holder JC, Holman GD, Kozka IJ, Kirkham DM, Lister CA, Smith SA. Young PW, et al. Among authors: smith sa. Diabetes. 1995 Sep;44(9):1087-92. doi: 10.2337/diab.44.9.1087. Diabetes. 1995. PMID: 7657033

9

[[omega-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents.

Cantello BC, Cawthorne MA, Cottam GP, Duff PT, Haigh D, Hindley RM, Lister CA, Smith SA, Thurlby PL. Cantello BC, et al. Among authors: smith sa. J Med Chem. 1994 Nov 11;37(23):3977-85. doi: 10.1021/jm00049a017. J Med Chem. 1994. PMID: 7966158

10

The contribution of classical (beta1/2-) and atypical beta-adrenoceptors to the stimulation of human white adipocyte lipolysis and right atrial appendage contraction by novel beta3-adrenoceptor agonists of differing selectivities.

Sennitt MV, Kaumann AJ, Molenaar P, Beeley LJ, Young PW, Kelly J, Chapman H, Henson SM, Berge JM, Dean DK, Kotecha NR, Morgan HK, Rami HK, Ward RW, Thompson M, Wilson S, Smith SA, Cawthorne MA, Stock MJ, Arch JR. Sennitt MV, et al. Among authors: smith sa. J Pharmacol Exp Ther. 1998 Jun;285(3):1084-95. J Pharmacol Exp Ther. 1998. PMID: 9618411

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,654 results

Search Page

Filters